Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2007
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007110782A1 Muscarinic receptor antagonists
10/04/2007WO2007110559A1 Pharmaceutically acceptable salts and polymorphic forms of sildenafil
10/04/2007WO2007110438A1 Imidazo [1,2 -b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007110437A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007092839A3 Macrocycle derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007WO2007091948A3 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007091947A3 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007083188A3 Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
10/04/2007WO2007072163A3 Pyrimidine derivatives
10/04/2007WO2007054831A3 Inhibitors of vegf receptor and hgf receptor signaling
10/04/2007US20070232838 Alcohol Oxidation Catalyst and Method of Synthesizing the Same
10/04/2007US20070232809 Processes of Preparing Glycolurils and Cucurbiturils Using Microwave
10/04/2007US20070232800 Organic electroluminescent device, and azepine compound and method for producing the same
10/04/2007US20070232630 MACROCYCLE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE)
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
10/04/2007US20070232623 Pyrazolopyrimidine and Pyrazolotriazine Derivatives and Pharmaceutical Compositions Containing Them
10/04/2007US20070232612 Octahydro-pyrrolo[3,4-b]pyrrole Derivatives
10/04/2007US20070232611 Amide Derivatives of 3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232604 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors
10/04/2007US20070232593 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES
10/04/2007US20070232587 4-Propionyl-(6-phenoxycarbonyl-6-azabicylo[3.2.2]non-3-ene; methyl-(2 alpha-phenyl-6-phenoxycarbonyl-6-azabicyclo[3.2.2]nona-3-ene)-4-carboxylate; bipolar disorders, depression, mood disorders, addictions, cognitive disorders, neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232521 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan
10/04/2007US20070227590 Supramolecular Complex of Pyridylnaphthalenediimide with Zinc Porphyrin Dendrimer Having Multiplicity of Artificial Photosynthetic Reaction Center
10/04/2007DE102007012627A1 Substituierte Imidazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schadpilzen sowie sie enthaltende Mittel Substituted imidazolopyrimidines, processes for their preparation and their use for controlling harmful fungi and to compositions comprising
10/04/2007CA2647116A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007CA2647045A1 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838718A1 Pyrrolopyrazoles, potent kinase inhibitors
10/03/2007EP1838713A2 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
10/03/2007EP1838712A1 Pyrazolopyrimidine compounds as antitumor agents
10/03/2007EP1838711A2 Anti-tumor compounds
10/03/2007EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
10/03/2007EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/03/2007EP1318151B1 Porphyrin compounds consisting of porphyrin rings fused in a single direction by three bonds, i.e., one meso-meso carbon bond and two beta-beta carbon bonds and process for their synthesis
10/03/2007EP1307458B1 Pyrrolotriazolopyrimidinone derivatives
10/03/2007CN101048411A Optical filter and its applications, and porphyrin compound used in optical filter
10/03/2007CN101048410A HIV inhibiting bicyclic pyrimidine derivatives
10/03/2007CN101048406A Novel substituted imidazole derivatives
10/03/2007CN101048405A Aryl-substituted piperazine derivatives
10/03/2007CN101048393A Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
10/03/2007CN101048390A Heterocyclical chromophore architectures
10/03/2007CN101045730A Preparation method of natural phyllo-iron zinc salt
10/03/2007CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
10/03/2007CN100340560C N,Núº-dipyridyl-equibenzyl-tetraformyldiimine derivative and its synthesis method
10/03/2007CN100340559C Nitrogen containing heterobicycles as factor XA inhibitors
10/02/2007US7276611 A bicyclic heteroaryl carboxaldehyde; nitrosation a corresponding amino acid; dehydration; neutralization; reacting with hydroxylamine; reducing the amide compound reducing reducing agents; isolation
10/02/2007US7276515 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases
10/02/2007US7276507 Pyridopyrazines and the use thereof as kinase inhibitors
10/02/2007US7276505 Immunomodulating heterocyclic compounds
10/02/2007US7276504 Nasally administering an imidazotriazinone substituted with an (alkoxy)(aminosulfonyl)phenyl group for treating diseases including psoriasis, female infertility, diabetes, glaucoma, cystic fibrosis, pre-eclampsia, Parkinsonism, tinnitus, pain, gastric motility disorders, and pulmonary hypertension
10/02/2007US7276496 Cyclic malonamides as inhibitors of Aβ protein protection
10/02/2007US7276495 Substituted lactams as inhibitors of Aβ protein production
10/02/2007US7276494 Photodynamic therapy; anticancer agents, vision defects, autoimmune disease, restenosis, skin disorders; cancer vaccine; medical diagnosis
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007US7276184 Surfactant assisted nanomaterial generation process
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
10/02/2007CA2262421C Substituted pyrrolopyrimidines and processes for their preparation
09/2007
09/27/2007WO2007109813A1 Imidazoquinoxaline compounds as immunomodulators
09/27/2007WO2007109362A2 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
09/27/2007WO2007109355A2 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
09/27/2007WO2007108968A2 Ophthalmic compositions for treating ocular hypertension
09/27/2007WO2007108006A1 Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
09/27/2007WO2007107346A1 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
09/27/2007WO2007107005A1 Inhibitors of protein tyrosine kinase activity
09/27/2007WO2007079164A3 Protein kinase inhibitors
09/27/2007WO2007018807A3 Methods and intermediates for the synthesis of porphyrins
09/27/2007US20070225493 Combining CL-20 organic solvent, nonsolvent to form a crystallization solution; saturating the crystallization solution;heating the crystallization solution to a temperature of from about 71 degrees C. to about 94 degrees C.; removing the at least one organic solvent and nonsolvent; separation
09/27/2007US20070225492 3,6-Diazabicyclo[3.1.1]Heptane Derivatives with Analgesic Activity
09/27/2007US20070225491 Phthalocyanine Derivatives, Their use as Homeotropically Aligned Layer in Electronic Devices and Method for the Manufacturing Thereof
09/27/2007US20070225319 Piperidinyl indole and tetrohydropyridinyl indole derivatives and methods of their use
09/27/2007US20070225306 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
09/27/2007US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/27/2007US20070225275 Tetrahydro-pyrimidoazepines as modulators of TRPV1
09/27/2007US20070225271 Pyrimidine, quinazoline, pteridine and triazine derivatives
09/27/2007US20070225270 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
09/27/2007US20070225170 2-Halo-6-Alkylphenyl-Substituted Tetramic Acid Derivatives
09/27/2007US20070225167 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides
09/27/2007US20070224529 Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium
09/27/2007CA2646977A1 6,7,8,9 -tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpvl for the treatment of pain
09/27/2007CA2646539A1 Imidazoquinoxaline compounds as immunomodulators
09/27/2007CA2645892A1 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
09/27/2007CA2645652A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
09/27/2007CA2643968A1 Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
09/26/2007EP1836209A1 Crystalline forms of6-[(5s,9r)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]nicotinic acid as inhibitors of cd18 integrins, icams and/or the lfa-1:icam interaction for the treatment of inflammations and immune diseases
09/26/2007EP1836208A2 AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE
09/26/2007EP1836207A2 Triazolophthalazines as pde2-inhibitors
09/26/2007EP1836206A1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
09/26/2007EP1836205A2 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS
09/26/2007EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues
09/26/2007EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/26/2007CN101044145A Imidazo-benzodiazepine derivatives
09/26/2007CN101044144A Novel diazabicyclic aryl derivatives as cholinergy ligands
09/26/2007CN101044143A Process for preparing purine compounds
09/26/2007CN101044140A Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof